2[2]Giuliani N. Hormone replacement therapy and osteoporosis. Scand J Rheumatol, 1998; 27 (1): 38～41
3[3]Nananda F, Mark H. Richard H et al. Patient-specific decisions about hormone replacement therapy in postrmenopausal women. JAMA, 1997; 277:1140～1147
4[4]Skoog I,Gustafson D. HRT and dementia. J Eidemiol Biostat,1999; 4 (3):: 165
5[5]Ruth AM, Carl WC, Claudia K et al. Estrogen replacement therapy for treatment of mils to moderate Alzheimer disease. JAMA, 2000;283: 1007～1015
6[6]Beral V, Banks E, Reeves G et al. Use of HRT and the subsequent risk of cancer. J Eidemiol Biostat, 1999; 4 (3): 191
7[7]Schneider HP. HRT and cancer risk: separating fact from fic-tion. Muturitas, 1993; 33: supply 565
8[8]Hempling. HRT and the risk of ovarian cancer. Obstet and Gy-necol, 1997; 89 (6): 1012～1016
9[9]Pirhonen JP, Vuento MH, Makinen JI et al. Long-term effects ofhormone replacement therapy on the uterus and on uterine circulation. Am J Obstet Gymecol, 1993; 168 (2): 620～630
10[10]Sener D, Akkad P, Mattsson. WHO collaborative study of neopla-sis and steroid conttraceptives. Int J cancer, 1989; 43: 254～259
5[8]Turpin G, Bruckert E, Datious F. Substi-tutive hormonal treatment of meno-pause effects on lipoprotein metabo-lism[J]. Press Med, 1995,24: 905-999.
6[9]Modena MG, Rossi R, Muia N, et al. Shortterm results of transdermal estrogen replacement therapy in cardiovascu-lar diseasefree postmenopausal females with and without hypertension [J]. Cltal Cardiol,1998,28:636-644.
7[10]Chen F, Lee N, Soong YK. Changes in the lipoprotein profile in postmeno-pausal women receiving hormone re-placement therapy. Effects of naturaland syntheticprogrestorone[J]. J Reprud Med , 1998,43:568-574.
8[11]Espeland MA, Mareovina SM, Miller V, et al. Effects of postmenopausal hormone therapy on liprotein (a) con-centration. PEPI Investigation. Postmenopausal Estrogen/Progestin Inter-ventions [J].Circulation, 1998,97: 979-986.
9[12]Francine Gaodstein. Sc D, Meir J. Stampfer MD, et al. Postmenopausal estrogens and progestin use and the risk of cardiovascular disease[J]. NEJM, 1996,335:453-461.
10[13]Eugenia E, Calle, Heidi L, et al. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women[J]. J Natl Cancer Inst, 1995,87: 517-523.
